ElringKlinger Preliminary Q1 EBIT Rises - Quick Facts

ElringKlinger AG (EGKLF.PK) said, according to preliminary figures, the Group generated earnings before interest and taxes (EBIT) of 48.4 million euros compared to 16.0 million euros, prior year. This corresponds to an EBIT margin of 11.4% compared to 4.0%.

According to preliminary figures, the Group generated first quarter revenue of 424 million euros compared to 396 million euros, a year ago.

ElringKlinger adjusted its guidance for the current financial year. The company said while organic revenue is still expected to develop roughly in line with market levels, the EBIT margin is now projected at around 5 to 6% (previously: around 4 to 5%).

ElringKlinger will publish its full quarterly results on May 6, 2021.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration approved Boehringer Ingelheim Pharmaceuticals, Inc.'s Pradaxa (dabigatran etexilate) oral blood thinning medication for children. Pradaxa is the first FDA-approved blood thinning medication that children can take by mouth. The only other approved blood thinning medication for children is given by injection. Amazon.com Inc.'s two-day Prime Day event is happening now with more than 2 million deals on offer. The e-commerce giant's biggest shopping extravaganza of the year started June 21 at 3 a.m. EDT and runs for 48 hours, through June 22. Prime Day 2021 will feature the largest number of deals ever offered in the seven year history of the Prime Day Celebrations. New deals are being launched throughout The European Commission announced Tuesday that it has opened a formal antitrust investigation to assess whether Google has violated EU competition rules by favoring its own online display advertising technology services in the so called "ad tech" supply chain, to the detriment of competing providers...
Follow RTT